Aminopyrimidine derivatives as LRRK2 modulators
0 Assignments
0 Petitions
Accused Products
Abstract
Specific Compounds of formula I:
-
- or pharmaceutically acceptable salts thereof,
- wherein m, X, R1, R2, R3, R5, R6 and R7 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson'"'"'s disease.
-
Citations
5 Claims
- 1. A compound of formula I:
-
4. The compound (4-(4-(cyclopropylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-fluoro-5-methoxyphenyl)(morpholino)methanone, or a pharmaceutical salt thereof.
-
5. The compound [4-(4-cyclopropylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-5-methoxy-2-methyl-phenyl]-morpholin-4-yl-methanone, or a pharmaceutical salt thereof.
Specification